107166-93-8 Usage
Description
2,4-Dimethoxy-5-iodo-6-methylpyrimidine is a pyrimidine derivative with the molecular formula C7H9IN2O2. It features a pyrimidine ring to which two methoxy groups, an iodine atom, and a methyl group are attached. This chemical compound is notable for its potential applications in the pharmaceutical industry, where it serves as a building block for the synthesis of biologically active molecules. Its distinctive structure and properties render it a valuable precursor in the development of new drugs and therapeutic agents, and it may also find use in organic chemistry as a reagent or intermediate in the synthesis of other compounds.
Uses
Used in Pharmaceutical Industry:
2,4-Dimethoxy-5-iodo-6-methylpyrimidine is used as a building block for the synthesis of various biologically active molecules, contributing to the development of new drugs and therapeutic agents. Its unique structure allows for the creation of compounds with specific pharmacological properties, making it a key component in medicinal chemistry.
Used in Organic Chemistry:
In the field of organic chemistry, 2,4-Dimethoxy-5-iodo-6-methylpyrimidine is utilized as a reagent or intermediate in the synthesis of other compounds. Its presence in chemical reactions can facilitate the formation of desired products, enhancing the efficiency and selectivity of organic synthesis processes.
Check Digit Verification of cas no
The CAS Registry Mumber 107166-93-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,1,6 and 6 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 107166-93:
(8*1)+(7*0)+(6*7)+(5*1)+(4*6)+(3*6)+(2*9)+(1*3)=118
118 % 10 = 8
So 107166-93-8 is a valid CAS Registry Number.
107166-93-8Relevant articles and documents
ALPHA,BETA-UNSATURATED MONOMERS CAPABLE OF MULTIMERIZATION IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME
-
, (2015/03/28)
Described herein are monomers capable of forming a biologically useful multimer when in contact with one, two, three or more other monomers in an aqueous media. In one aspect, such monomers may be capable of binding to another monomer in an aqueous media (e.g. in vivo) to form a multimer, (e.g. a dimer). Contemplated monomers may include a ligand moiety, a linker element, and a connector element that joins the ligand moiety and the linker element. In an aqueous media, such contemplated monomers may join together via each linker element and may thus be capable of modulating one or more biomolecules substantially simultaneously, e.g., modulate two or more binding domains on a protein or on different proteins.
Sparsomycin Analogs. IV. Synthesis and antitumor activity of pyrimidine-5-carboxamides and (E)-β-(pyrimidin-5-yl)-acrylamides
Kanatomo,Wada,Yomei,Hase,Nagai,Fukuda,Tanaka,Sasaki
, p. 2042 - 2049 (2007/10/02)
-
A Convenient Synthesis of Methyl (E)-β-Pyrimidinylacrylates
Wada, Akimori,Yamamoto, Junpei,Hase, Tetsuko,Nagai, Sotoo,Kanatomo, Shoichi
, p. 555 - 556 (2007/10/02)
A convenient synthesis of methyl (E)-β-pyrimidinylacrylates 5 is described. 5-Halopyrimidines react smoothly with methyl acrylate in the presence of palladium diacetate-triphenylphosphine complex in triethylamine to afford methyl (E)-β-pyrimidinylacrylates in satisfactory yields.Using this method an improved preparation of (E)-β-(2,4-dioxo-6-methyl-1,2,3,4-tetrahydropyrimidin-5-yl)acrylic acid is reported.
